| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 24 Feb 2025 | 24 Feb 2025 |
| Appointment of CS Aarefa Kutub Kapasi, (ICSI M. No. A37110) as a Company Secretary and Compliance Officer of the Company w.e.f. 24th February, 2025 | ||
| Board Meeting | 28 Jan 2025 | 28 Jan 2025 |
| Pursuant to the Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Board of Directors of the Company at its Meeting held today have inter-alia, considered and approved the following matter The DLOF for raising of Funds by way of Right Issue of equity shares of the Company of face value Rs. 10/- each at such price, at a premium or discount to the market price such that the aggregate value (including premium, if any) does not exceed Rs. 50,00,00,000/- , to the eligible equity shareholders of the Company as on record date (to be determined by the Board in due course) subject to receipt of statutory/regulatory approvals, as may be applicable in accordance with the relevant regulations, circulars, notifications issued by the SEBI and any other law as may be applicable.Kindly note that the meeting of the Board of Directors commenced at 05:00 P.M. and concluded at 08:00 P.M. | ||
| Board Meeting | 8 Jan 2025 | 3 Jan 2025 |
| Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/01/2025 inter alia to consider and approve proposal for fund raising through the issue of equity shares of the Company on Rights Basis to existing equity shareholders of the Company as may be permitted under applicable law subject to such regulatory and/or statutory approvals as may be applicable Intimation of Trading window closure for Board Meeting dated 08th January, 2024 for proposal of fundraising through right issue Raising of Funds by way of issue of equity shares of the Company of face value Rs. 10/- (Rupees Ten Only) each through Right Issue for an amount not exceeding Rs. 50,00,00,000 (Rupees Fifty Crore Only) to the eligible equity shareholders of the Company as on record date (to be determined by the Board in due course) subject to the receipt of statutory/regulatory approvals, as may be applicable in accordance with the Securities and Exchange Board of India and other applicable law. (As Per BSE Announcement Dated on: 08/01/2025) | ||
| Board Meeting | 30 Oct 2024 | 24 Oct 2024 |
| Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2024 inter alia to consider and approve Unaudited Standalone Financial Result of the Company for the Half Year Ended on 30th September 2024 Approval of Standalone Unaudited Financial Result for the Half Year ended on 30th September, 2024 as per Regulation 33 of the SEBI (LODR) Regulations, 2015 along with Limited Review report (As Per BSE Announcement Dated on 30.10.2024) | ||
| Board Meeting | 7 Sep 2024 | 4 Sep 2024 |
| Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/09/2024 inter alia to consider and approve 1. To consider and approve the Draft Notice for calling 17th Annual General Meeting 2. To Approve the Draft of Directors Report 3. To Recommendation a final dividend @ 3.3% (i.e Rs. 0.33/-) per equity share of Rs. 10/- 4. To consider and approve the increase in the Authorized Share Capital of the Company 5. To consider and approve a change in terms of payment of remuneration to Mr. Mustaqim Nisarahmed Sabugar Managing Director (Din: 01456841) of the company 6. To consider and approve a change in terms of payment of remuneration of Mr. Shakil Nisarahmed Sabugar Whole-Time Director (Din: 01474868) of the company Board in its meeting dated 07th September, 2024 approved final dividend at the rate of 3.30% subject to approval of Member at 17th AGM (As Per BSE Announcement dated on 07.09.2024) | ||
| Board Meeting | 8 Aug 2024 | 8 Aug 2024 |
| Resignation And Appointment of Internal Auditor | ||
| Board Meeting | 24 May 2024 | 17 May 2024 |
| Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve To consider approve and take on record the Audited Financial Results for the half year ended and year ended on March 31 2024 as per Regulation 33 of the SEBI (LODR) Regulation 2015 Reappointment of Secretarial Auditor M/S Murtuza Mandorwala & Associates for the financial year 2024-2025 Approval of Audited Financial Result for Half year and Financial year ended on 31st March, 2024 (As Per BSE Announcement dated on 24.05.2024) Reappointment of Internal Auditor M/S Altaf Sachora & Co for the financial year 2024-2025 (As Per BSE Announcement Dated on 25/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
